Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 18, 2022 Filed Feb 22, 2022 21:39 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,490 | $0.00 Strike: $29.78 | $0.00 |
DisclosureSEC source: 0001179110-22-001491 · edgar.xml · derivative · entry 12 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,490 shares Expires 2022-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 10, 2017 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:39 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
SaleCommon Stock | 26,790 | $68.51 | $1,835,297.17 |
DisclosureSEC source: 0001179110-22-001491 · edgar.xml · nonDerivative · entry 4 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,474,523 F6 · kind: Reflects 26,790 shares sold by the Reporting Person at the market price of $68.5068 per share less an exercise price of $29.777 per share to fund the cashless exercise of 40,490 options. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.13 to $68.75, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 21:39 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionCommon Stock | 40,490 | $29.78 | $1,205,670.73 |
DisclosureSEC source: 0001179110-22-001491 · edgar.xml · nonDerivative · entry 3 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,501,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 21:39 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 43,847 | $0.00 Strike: $29.78 | $0.00 |
DisclosureSEC source: 0001179110-22-001491 · edgar.xml · derivative · entry 11 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 43,847 shares Expires 2022-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 10, 2017 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 21:39 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
SaleCommon Stock | 26,200 | $68.12 | $1,784,744.00 |
DisclosureSEC source: 0001179110-22-001491 · edgar.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,460,823 F5 · kind: Reflects 26,200 shares sold by the Reporting Person at the market price of $68.12 per share less an exercise price of $29.777 per share to fund the cashless exercise of 43,847 options. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.91 to $68.38, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 21:39 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionCommon Stock | 43,847 | $29.78 | $1,305,632.12 |
DisclosureSEC source: 0001179110-22-001491 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,487,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:10 UTC |
ROSENTHAL BOBDirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000304 · edgar.xml · nonDerivative · entry 1 ROSENTHAL BOB · CIK 0001203911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,800 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:09 UTC |
Requardt Hermann FritzDirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000302 · edgar.xml · nonDerivative · entry 1 Requardt Hermann Fritz · CIK 0001651105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,800 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:08 UTC |
PACKER RICHARD ADirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000298 · edgar.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,907 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:09 UTC |
Perkins Adelene QDirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000300 · edgar.xml · nonDerivative · entry 1 Perkins Adelene Q · CIK 0001375124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,979 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:07 UTC |
ORNELL JOHN ADirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000296 · edgar.xml · nonDerivative · entry 1 ORNELL JOHN A · CIK 0001186875 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,800 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:07 UTC |
LINTON WILLIAM ADirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000293 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,078 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:06 UTC |
Kastner Marc ADirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000291 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,987 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:04 UTC |
Friend Cynthia MDirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000287 · edgar.xml · nonDerivative · entry 1 Friend Cynthia M · CIK 0001675108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,527 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. Read SEC document |
| January 05, 2022 Filed Jan 6, 2022 21:03 UTC |
Anderson Bonnie HDirector
|
GrantCommon Stock | 1,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000284 · edgar.xml · nonDerivative · entry 1 Anderson Bonnie H · CIK 0001588970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,682 F1 · shares: This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock. F2 · balance_after: Includes 1,539 shares held by Trust, for which the Reporting Person is the sole beneficiary. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:04 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Tax withholdingCommon Stock | 1,243 | $78.78 | $97,923.54 |
DisclosureSEC source: 0001179110-21-011106 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,443,176 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:16 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 21,210 | $0.00 Strike: $19.82 | $0.00 |
DisclosureSEC source: 0001179110-21-011035 · edgar.xml · derivative · entry 3 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,210 shares Expires 2025-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:16 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
SaleCommon Stock | 21,210 | $79.47 | $1,685,647.78 |
DisclosureSEC source: 0001179110-21-011035 · edgar.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,064 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.60 to $80.54, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 21:16 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Exercise / conversionCommon Stock | 21,210 | $19.82 | $420,382.20 |
DisclosureSEC source: 0001179110-21-011035 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:02 UTC |
Kastner Marc ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 10,000 | $0.00 Strike: $19.90 | $0.00 |
DisclosureSEC source: 0001179110-21-010437 · edgar.xml · derivative · entry 3 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option granted to the Reporting Person on May 28, 2015 (the "Original Grant Date") vested in equal installments on the first, second and third anniversaries of the Original Grant Date. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:02 UTC |
Kastner Marc ADirector
|
SaleCommon Stock | 10,000 | $76.86 | $768,600.00 |
DisclosureSEC source: 0001179110-21-010437 · edgar.xml · nonDerivative · entry 2 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,146 Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 21:02 UTC |
Kastner Marc ADirector
|
Exercise / conversionCommon Stock | 10,000 | $19.90 | $199,000.00 |
DisclosureSEC source: 0001179110-21-010437 · edgar.xml · nonDerivative · entry 1 Kastner Marc A · CIK 0001570183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:16 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 6,000 | $0.00 Strike: $12.77 | $0.00 |
DisclosureSEC source: 0001179110-21-009825 · edgar.xml · derivative · entry 2 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2022-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested in three approximately equal annual installments on January 05, 2013, 2014 and 2015. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:16 UTC |
LINTON WILLIAM ADirector
|
Exercise / conversionCommon Stock | 6,000 | $12.77 | $76,620.00 |
DisclosureSEC source: 0001179110-21-009825 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 39,468 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · derivative · entry 9 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,468 shares Expires 2026-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 35,438 | $0.00 Strike: $19.82 | $0.00 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · derivative · entry 8 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,438 shares Expires 2025-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option granted to the Reporting Person on August 7, 2015 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 25,369 | $0.00 Strike: $20.68 | $0.00 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · derivative · entry 7 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,369 shares Expires 2024-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 8, 2014 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 90,000 | $0.00 Strike: $18.57 | $0.00 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · derivative · entry 6 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,000 shares Expires 2023-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option granted to the Reporting Person on April 3, 2013 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
SaleCommon Stock | 202,216 | $89.54 | $18,106,359.98 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · nonDerivative · entry 5 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,936 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.5014 to $90.15, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
Exercise / conversionCommon Stock | 39,468 | $22.19 | $875,794.92 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · nonDerivative · entry 4 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
Exercise / conversionCommon Stock | 35,438 | $19.82 | $702,381.16 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · nonDerivative · entry 3 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
Exercise / conversionCommon Stock | 25,369 | $20.68 | $524,630.92 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · nonDerivative · entry 2 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:02 UTC |
Srega JuergenGroup President Bruker CALID
|
Exercise / conversionCommon Stock | 90,000 | $18.57 | $1,671,300.00 |
DisclosureSEC source: 0001179110-21-008582 · edgar.xml · nonDerivative · entry 1 Srega Juergen · CIK 0001569832 · Group President Bruker CALID 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 20:10 UTC |
LINTON WILLIAM ADirector
|
GiftCommon Stock | 84,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008531 · edgar.xml · nonDerivative · entry 1 LINTON WILLIAM A · CIK 0001243154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,237 F1 · shares: This transaction represents a charitable donation by the reporting person to Usona Institute, a 501(c)(3) organization. F2 · price: Price is not applicable to dispositions resulting from bona fide gifts. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:12 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 129,284 | $0.00 Strike: $24.41 | $0.00 |
DisclosureSEC source: 0001179110-21-008283 · edgar.xml · derivative · entry 9 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 129,284 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:12 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
SaleCommon Stock | 71,594 | $83.83 | $6,001,775.14 |
DisclosureSEC source: 0001179110-21-008283 · edgar.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,444,419 F3 · kind: Reflects shares sold to cover the Reporting Person's exercise price and tax liability in connection with the exercise of stock options. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.76 to $84.04, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:12 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Exercise / conversionCommon Stock | 129,284 | $24.41 | $3,155,693.16 |
DisclosureSEC source: 0001179110-21-008283 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,516,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 923 | $0.00 Strike: $43.50 | $0.00 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · derivative · entry 9 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 923 shares Expires 2030-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option granted to the Reporting Person on August 6, 2020 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 1,903 | $0.00 Strike: $41.95 | $0.00 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · derivative · entry 8 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,903 shares Expires 2029-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option granted to the Reporting Person on August 8, 2019 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 3,249 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · derivative · entry 7 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,249 shares Expires 2028-08-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option granted to the Reporting Person on August 9, 2018 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 4,371 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · derivative · entry 6 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,371 shares Expires 2026-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option granted to the Reporting Person on October 4, 2016 (the "Original Grant Date") vested in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
SaleCommon Stock | 10,446 | $83.66 | $873,874.75 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · nonDerivative · entry 5 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,123 F5 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionCommon Stock | 923 | $43.50 | $40,150.50 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · nonDerivative · entry 4 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionCommon Stock | 1,903 | $41.95 | $79,830.85 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · nonDerivative · entry 3 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionCommon Stock | 3,249 | $34.02 | $110,530.98 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · nonDerivative · entry 2 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 21:06 UTC |
Prause BurkhardPres. & CEO, Bruker EST
|
Exercise / conversionCommon Stock | 4,371 | $22.19 | $96,992.49 |
DisclosureSEC source: 0001179110-21-008281 · edgar.xml · nonDerivative · entry 1 Prause Burkhard · CIK 0001544726 · Pres. & CEO, Bruker EST 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:34 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 2,989 | $82.61 | $246,921.29 |
DisclosureSEC source: 0001179110-21-008134 · edgar.xml · nonDerivative · entry 1 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,064 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 22:32 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Tax withholdingCommon Stock | 7,496 | $82.61 | $619,244.56 |
DisclosureSEC source: 0001179110-21-008133 · edgar.xml · nonDerivative · entry 1 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,386,729 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 20:05 UTC |
LAUKIEN FRANK HDirector · CEO, President · 10% owner
|
Tax withholdingCommon Stock | 6,019 | $82.85 | $498,674.15 |
DisclosureSEC source: 0001179110-21-008078 · edgar.xml · nonDerivative · entry 2 LAUKIEN FRANK H · CIK 0001133649 · Director · CEO, President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,394,225 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 20:03 UTC |
Munch MarkExec VP&Pres Bruker Nano Inc.
|
Tax withholdingCommon Stock | 2,354 | $82.85 | $195,028.90 |
DisclosureSEC source: 0001179110-21-008076 · edgar.xml · nonDerivative · entry 2 Munch Mark · CIK 0001544635 · Exec VP&Pres Bruker Nano Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,053 F1 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.